Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, F2

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, F2

Definition : Molecular assay reagents intended to identify mutations in the coagulation factor II (thrombin) (F2) gene, located at chromosome 11p11-q12, which encodes for the protein thrombin that converts fibrinogen to fibrin. Mutations at this locus have been identified in patients with dysprothrombinemia and as a risk factor for cerebrovascular ischemic disease, deep vein thrombosis, and idiopathic portal vein thrombosis.

Entry Terms : "Thrombosis Gene Mutation Detection Reagents" , "Portal Vein Thrombosis Gene Mutation Detection Reagents" , "Deep Vein Thrombosis Gene Mutation Detection Reagents" , "Cerebrovascular Ischemic Disease Risk Gene Mutation Detection Reagents" , "Dysprothrombinemia Gene Mutation Detection Reagents" , "Thrombophilia Gene Mutation Detection Reagents" , "F2 Gene Mutation Detection Reagents" , "Thrombophilia Diagnostic Reagents" , "IVD Test Reagent/Kits, Molecular Assay, Inborn Disorder, Monogenic, Thrombophilia" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, F2"

UMDC code : 24407

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-6 of 6 Match(es).

AutoGenomics Inc

Company Type: Parent

AutoGenomics, Inc., a privately held company based in Vista, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genetic biomarkers in the areas of women's health, cancer and personalized medicine. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to a new era of personalized medicine.

GenMark Diagnostics Inc

Company Type: Parent

GenMark Diagnostics is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges.

Hologic Inc

Company Type: Parent

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world.

Maine Molecular Quality Controls Inc

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

Nanosphere Inc

Company Type: Parent

Nanosphere develops, manufactures and markets an advanced molecular diagnostic platform, the Verigene System, which enables simple, cost-effective, and highly sensitive nucleic acid (DNA and RNA) and protein testing on a single platform.

1-6 of 6 Match(es).